Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Miyako Capital

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 41
Average round size
info
The average size of a deal this fund participated in
$7M
Portfolio companies 31
Rounds per year 3.73
Lead investments 4
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.24
Exits 2
Key employees 1

Areas of investment

  • Medical
  • Software
  • Biotechnology
  • Manufacturing
  • Health Care
Summary

Miyako Capital is the famous VC, which was founded in 2013. The leading representative office of defined VC is situated in the Kyoto. The venture was found in Asia in Japan.

For fund there is a match between the country of its foundation and the country of its the most frequent investments - Japan. The fund has exact preference in some founders of portfolio startups. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. Among the most popular fund investment industries, there are Mobile Apps, Machine Learning. Among the various public portfolio startups of the fund, we may underline Hacarus, iHeart Japan, Drivemode

The fund is generally included in 2-6 deals every year. The usual things for fund are deals in the range of 1 - 5 millions dollars. The increased amount of exits for fund were in 2019. Speaking about the real fund results, this VC is 30 percentage points more often commits exit comparing to other organizations. This Miyako Capital works on 12 percentage points less the average amount of lead investments comparing to the other organizations. The important activity for fund was in 2017.

The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the Miyako Capital, startups are often financed by VenGrowth Asset Management, UTEC- University of Tokyo Edge Capital, BDC Venture Capital. The meaningful sponsors for the fund in investment in the same round are Nissay Capital, Senshu Ikeda Capital, SMBC Venture Capital. In the next rounds fund is usually obtained by SBI Investment, Eight Roads Ventures, SMBC Venture Capital.

The overall number of key employees were 2.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Miyako Capital:
Typical Co-investors
Miyako Capital is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Miyako Capital:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Aegon Den Haag, The Netherlands, Zuid-Holland
Beijing Xing Pai Group Beijing, Beijing, China
Cancer Research Technology England, London, United Kingdom
Continental Bank -
Daiwa Energy Infrastructure -
Forticom Latvia, Riga, Vidzeme
Gund Investment, LLC New Jersey, Princeton, United States
ILJIN Life Science -
indaa.com.cn Beijing, Beijing, China
Maj Invest Equity Copenhagen, Denmark, Hovedstaden
McGraw Hill Financial New York, New York, United States
Muscular Dystrophy Association Chicago, Illinois, United States
Northpoint Financial Group California, Pleasanton, United States
Promon International -
RapidTainment Cham, Switzerland, Zug
Securian Financial Group Minnesota, Saint Paul, United States
UC Capital Barcelona, Brazil, Rio Grande do Norte
Zhongtianlida Feng Tou Beijing, Beijing, China

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

LocationMind

Information Technology
Internet of Things
Security
$7M17 Jan 2024 Chiyoda, Japan

Sakana AI

Information Technology
$30M16 Jan 2024 Tokyo, Kantō, Japan

Nota

Collaboration
Developer Tools
Mobile
Mobile Apps
$5M05 Sep 2022 Kyoto, Kyoto Prefecture, Japan

Social Good Foundation Inc.

Blockchain
Cryptocurrency
Ethereum
FinTech
$14M02 Mar 2022 Chiyoda, Japan

Viage Therapeutics

Biotechnology
Clinical Trials
Medical
$10M06 Jan 2022 San Francisco, California, United States

VLP Therapeutics

Biotechnology
Health Care
Medical
Medical Device
$21M27 Dec 2021 Maryland, United States

ALGO ARTIS

Logistics
Professional Services
Software
$4M15 Sep 2021 Tokyo, Kantō, Japan

VividQ

3D Technology
Augmented Reality
Software
Virtual Reality
$15M01 Jul 2021 Cambridge, England, United Kingdom

Startbahn

Art
Blockchain
Information Technology
$10M12 May 2021 Chiyoda, Japan

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Miyako Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 41
Average round size 7M
Rounds per year 3.73
Peak activity year 2017
Lead investments 4
Follow on index 0.24
Exits 2
Group Appearance index 0.98

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

LocationMind

Information Technology
Internet of Things
Security
$7M17 Jan 2024 Chiyoda, Japan

Sakana AI

Information Technology
$30M16 Jan 2024 Tokyo, Kantō, Japan

Nota

Collaboration
Developer Tools
Mobile
Mobile Apps
$5M05 Sep 2022 Kyoto, Kyoto Prefecture, Japan

Social Good Foundation Inc.

Blockchain
Cryptocurrency
Ethereum
FinTech
$14M02 Mar 2022 Chiyoda, Japan

Viage Therapeutics

Biotechnology
Clinical Trials
Medical
$10M06 Jan 2022 San Francisco, California, United States

VLP Therapeutics

Biotechnology
Health Care
Medical
Medical Device
$21M27 Dec 2021 Maryland, United States

ALGO ARTIS

Logistics
Professional Services
Software
$4M15 Sep 2021 Tokyo, Kantō, Japan

VividQ

3D Technology
Augmented Reality
Software
Virtual Reality
$15M01 Jul 2021 Cambridge, England, United Kingdom

Startbahn

Art
Blockchain
Information Technology
$10M12 May 2021 Chiyoda, Japan
Crunchbase icon

Content report

The following text will be sent to our editors: